Securities class actions have been filed on behalf of investors in Wix.com Ltd., PROCEPT BioRobotics Corporation and Pentair plc, with lead plaintiff deadlines of September 22, 2026, for Wix and Procept and October 2, 2026, for Pentair. Robbins Geller Rudman & Dowd LLP is notifying Wix investors in Yappi v. Wix.com Ltd., No. 26-cv-08852 (N.D. Ill.), covering purchases from February 19, 2025, through May 12, 2026, while Frank R. Cruz and Hagens Berman have also addressed the Wix claims alongside separate Procept and Pentair suits. The Wix complaints allege the company overstated the competitiveness, performance and financial benefits of its AI offerings, including Base44—acquired in June 2025—and Harmony, while understating related development and promotion costs. Subsequent disclosures included May 2025 revenue guidance of $1.97 billion to $2 billion that fell short of analyst expectations, November 2025 commentary on Base44-related cost pressures, a series of 2026 analyst downgrades, and May 13, 2026, results showing earnings and revenue below consensus with sharply weaker operating margins; Wix shares fell more than 16%, nearly 20%, and more than 27% on major disclosure dates, among other declines. Wix also reported non-GAAP sales and marketing expenses of $190.7 million, up 88% year over year, with non-GAAP operating margin falling from 21% to 5%. The Procept case alleges an undisclosed discount program inflated handpiece sales and left more than 10,000 excess field units, while the Pentair case alleges undisclosed Pool-channel destocking hurt sales and operating income. Investors need not seek lead plaintiff status to remain absent class members.